INUTX | VIVIX | INUTX / VIVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 36 years | 26 years | - |
Gain YTD | 18.187 | 17.922 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.21B | 184B | 1% |
Annual Yield % from dividends | 2.64 | 2.37 | 112% |
Returns for 1 year | 26.63 | 25.54 | 104% |
Returns for 3 years | 7.30 | 21.57 | 34% |
Returns for 5 years | 20.95 | 50.79 | 41% |
Returns for 10 years | 10.27 | 110.50 | 9% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FMUIX | 14.89 | -0.07 | -0.47% |
Federated Hermes Muni and Stock Adv IS | |||
TAGDX | 15.35 | -0.22 | -1.41% |
Transamerica Large Growth R6 | |||
GSAHX | 15.78 | -0.30 | -1.87% |
Goldman Sachs Small Cap Growth Investor | |||
AMIGX | 82.60 | -1.65 | -1.96% |
Amana Growth Institutional | |||
LHCVX | 19.79 | -0.68 | -3.32% |
Lord Abbett Health Care R6 |